These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Endovascular irradiation from beta-particle-emitting gold stents results in increased neointima formation in a porcine restenosis model. Schulz C; Niederer C; Andres C; Herrmann RA; Lin X; Henkelmann R; Panzer W; Herrmann C; Regulla DF; Wolf I; Ulm K; Alt E Circulation; 2000 Apr; 101(16):1970-5. PubMed ID: 10779464 [TBL] [Abstract][Full Text] [Related]
25. Neointimal hyperplasia and late pathologic remodeling in a porcine coronary stent model. De Scheerder I ; Wang K; Zhou XR; Verbeken E; Ping QB; Yanming H; Jianhua H; Szilard M; Van de Werf F J Invasive Cardiol; 1999 Jan; 11(1):9-12. PubMed ID: 10745430 [TBL] [Abstract][Full Text] [Related]
26. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Komatsu R; Ueda M; Naruko T; Kojima A; Becker AE Circulation; 1998 Jul; 98(3):224-33. PubMed ID: 9697822 [TBL] [Abstract][Full Text] [Related]
27. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model. Kipshidze NN; Iversen P; Kim HS; Yiazdi H; Dangas G; Seaborn R; New G; Tio F; Waksman R; Mehran R; Tsapenko M; Stone GW; Roubin GS; Iyer S; Leon MB; Moses JW Catheter Cardiovasc Interv; 2004 Apr; 61(4):518-27. PubMed ID: 15065150 [TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of neointimal distribution of in-stent restenosis in patients with diabetes mellitus. Kaneda H; Ako J; Kataoka T; Takahashi T; Terashima M; Waseda K; Miyazawa A; Hassan A; Honda Y; Yock PG; Fitzgerald PJ Am J Cardiol; 2006 Feb; 97(3):340-2. PubMed ID: 16442392 [TBL] [Abstract][Full Text] [Related]
29. Segmental vessel wall shear stress and neointimal formation after sirolimus-eluting stent implantation: physiological insights in a porcine coronary model. Carter AJ; Wei W; Gibson L; Collingwood R; Tio F; Dooley J; Kopia GA Cardiovasc Revasc Med; 2005; 6(2):58-64. PubMed ID: 16263360 [TBL] [Abstract][Full Text] [Related]
30. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis. Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911 [TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study. Schiele F; Batur MK; Seronde MF; Meneveau N; Sewoke P; Bassignot A; Couetdic G; Caulfield F; Bassand JP Heart; 2001 Mar; 85(3):304-11. PubMed ID: 11179272 [TBL] [Abstract][Full Text] [Related]
32. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304 [TBL] [Abstract][Full Text] [Related]
34. In vivo uptake of radiolabeled antibody to proliferating smooth muscle cells in a swine model of coronary stent restenosis. Johnson LL; Schofield LM; Verdesca SA; Sharaf BL; Jones RM; Virmani R; Khaw BA J Nucl Med; 2000 Sep; 41(9):1535-40. PubMed ID: 10994735 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost. Alt E; Haehnel I; Beilharz C; Prietzel K; Preter D; Stemberger A; Fliedner T; Erhardt W; Schömig A Circulation; 2000 Mar; 101(12):1453-8. PubMed ID: 10736292 [TBL] [Abstract][Full Text] [Related]
36. Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results. Gercken U; Lansky AJ; Buellesfeld L; Desai K; Badereldin M; Mueller R; Selbach G; Leon MB; Grube E Catheter Cardiovasc Interv; 2002 Jul; 56(3):353-60. PubMed ID: 12112888 [TBL] [Abstract][Full Text] [Related]
37. [Stent-induced changes of coronary morphology--pathologic-anatomic and experimental findings after balloon expansion]. Grewe PH; Deneke T; Müller KM Z Kardiol; 2001 Sep; 90(9):630-6. PubMed ID: 11677799 [TBL] [Abstract][Full Text] [Related]
38. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries. Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624 [TBL] [Abstract][Full Text] [Related]
39. Restenosis following placement of an intracoronary heparin treated tantulum stent in the hyperlipidemic miniature swine model. Jenkins JS; Webel R; Laughlin MH; Rowland SM; Yoklavich MF; Amann JF; Branson K; Myers PR J Invasive Cardiol; 1995; 7(6):173-82. PubMed ID: 10155102 [TBL] [Abstract][Full Text] [Related]
40. A paclitaxel-eluting stent for the prevention of coronary restenosis. Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]